THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 123 filers reported holding THERAVANCE BIOPHARMA INC in Q1 2022. The put-call ratio across all filers is 3.73 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,813 | +1265.5% | 325,985 | +1536.4% | 0.24% | +1047.6% |
| Q2 2023 | $206 | -82.0% | 19,921 | -81.1% | 0.02% | -81.4% |
| Q1 2023 | $1,142 | +76.8% | 105,263 | +82.8% | 0.11% | +41.2% |
| Q4 2022 | $646 | -99.9% | 57,577 | -49.8% | 0.08% | -48.7% |
| Q2 2022 | $1,039,000 | +119.7% | 114,646 | +131.8% | 0.16% | +147.6% |
| Q1 2022 | $473,000 | +129.6% | 49,456 | +254.1% | 0.06% | +85.3% |
| Q3 2020 | $206,000 | -1.4% | 13,965 | +30.0% | 0.03% | +21.4% |
| Q3 2019 | $209,000 | – | 10,745 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madison Avenue Partners, LP | 7,012,226 | $60,515,510 | 8.59% |
| Irenic Capital Management LP | 2,760,948 | $23,826,981 | 6.76% |
| Newtyn Management, LLC | 1,841,560 | $15,892,663 | 3.92% |
| Weiss Asset Management LP | 7,457,060 | $64,354,428 | 3.81% |
| Park West Asset Management LLC | 1,983,251 | $17,115,456 | 1.57% |
| Baupost Group | 7,419,226 | $64,028 | 1.23% |
| Oasis Management Co Ltd. | 953,254 | $8,226,582 | 0.36% |
| Chescapmanager LLC | 287,333 | $2,479,684 | 0.32% |
| GSA CAPITAL PARTNERS LLP | 325,985 | $2,813 | 0.24% |
| Virtus ETF Advisers LLC | 29,232 | $252,272 | 0.15% |